Supporting strategic fundamental research in life sciences through carefully selected projects from universities in the Wallonia-Brussels Federation, with a view to transforming their discoveries into industrial applications.
Decio Eizirik (WELBIO / ULB) et son équipe décrivent des signatures moléculaires similaires entre différentes maladies auto-immunes, identifiant des voies clés qui pourraient être ciblées pour la thérapie.
Cédric Blanpain (WELBIO – ULB) and his team identify the functions of FAT1, one of the most frequently mutated cancer gene drivers, uncovering that FAT1 mutations promote invasive features, metastasis and resistance to commonly used anti-cancer drugs
Director of the Laboratory of Stem Cells and Cancer (ULB), WELBIO investigator, Pr. Cédric Blanpain is awarded the Francqui-Collen Prize for his fundamental research in cancer and stem cells biology.
WELBIO's essential mission is to support top level fundamental research in life sciences. This mission is currently integrated with the Fonds de la Recherche Fondamentale Stratégique (F.R.S.-FNRS).
WELBIO supports fundamental research with the view to translate scientific results into industrial applications. Through valorisation committees, a sustained focus is kept on the protection of intellectual property in particular.
The WELBIO Bridge Fund is a research funding instrument intended for WELBIO investigators and designed to bridge the gap between early stage research and the development of a competitive package for the next funding step
With its focus on life sciences, WELBIO holds a unique position between fundamental research in all fields and applied biomedical research sur les sciences du vivant. WELBIO works closely with the FRNS and BioWin in particular.
